These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 3063286

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of captopril and of other antihypertensive drugs on cell membrane ion transport--a preliminary report.
    Niutta E, Tripodi MG, Cusi D, Pati C, Dossi F, Elli A, Bianchi G.
    Postgrad Med J; 1986; 62 Suppl 1():13-5. PubMed ID: 3534847
    [Abstract] [Full Text] [Related]

  • 4. Effects of canrenoate on red cell sodium transport and calf flow in essential hypertension.
    Semplicini A, Buzzaccarini F, Ceolotto G, Marzola M, Mozzato MG, Giusto M, Campagnolo M, Simonella C, Pessina AC.
    Am J Hypertens; 1993 Apr; 6(4):295-301. PubMed ID: 8507449
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of K+-canrenoate on the development of DOCA-salt hypertension.
    Vargas F, Haro JM, Jodar E, Soler A, Garcia del Rio C.
    J Pharm Pharmacol; 1989 May; 41(5):335-8. PubMed ID: 2569521
    [Abstract] [Full Text] [Related]

  • 7. Acute effect of potassium canrenoate administration on renin-angiotensin, kallikrein-kinin and prostaglandin systems.
    Lahera V, Cachofeiro V, Duran F, Cañizo FJ, Rodriguez FJ, Tresguerres JA.
    Gen Pharmacol; 1988 May; 19(6):835-9. PubMed ID: 3068096
    [Abstract] [Full Text] [Related]

  • 8. Acute effects of angiotensin-converting enzyme inhibitor on erythrocyte sodium ion transport in essential hypertension.
    Fujito K, Yokomatsu M, Numahata H, Ishiguro N, Koide H.
    Life Sci; 1992 May; 51(26):2079-87. PubMed ID: 1335539
    [Abstract] [Full Text] [Related]

  • 9. Captopril and atenolol combined with hydrochlorothiazide in essential hypertension.
    Andrén L, Karlberg B, Ohman P, Svensson A, Asplund J, Hansson L.
    Br J Clin Pharmacol; 1982 May; 14 Suppl 2(Suppl 2):107S-111S. PubMed ID: 6753891
    [Abstract] [Full Text] [Related]

  • 10. Plasma renin activity and norepinephrine as predictors for antihypertensive effects of nifedipine and captopril.
    Kusaka M, Atarashi K, Matsumoto K, Sumida Y, Matsuura H, Shingu T, Kajiyama G.
    Am J Hypertens; 1991 Sep; 4(9):735-9. PubMed ID: 1930858
    [Abstract] [Full Text] [Related]

  • 11. [Antihypertensive effects of captopril, hydrochlorothiazide, alone or in combination, with different categories of essential hypertensive patients].
    Senn N, Ollivier JP, Abitbol JP, Garay R.
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():155-8. PubMed ID: 3142400
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of captopril on arterial blood pressure, plasma renin activity and vasopressin concentration in sodium-repleted and sodium-deficient goats. A serial study during pregnancy, lactation and anestrus.
    Olsson K, Fyhrquist F, Benlamlih S, Dahlborn K.
    Acta Physiol Scand; 1984 May; 121(1):73-80. PubMed ID: 6377825
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The antihypertensive and renal activities of potassium canrenoate are associated with increased renal prostaglandin excretion.
    Castellani S, Scarti L, Chen JL, Del Rosso A, Carnovali M, Masotti G.
    Clin Sci (Lond); 1989 Aug; 77(2):217-22. PubMed ID: 2766661
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the hypotensive effects of captopril and atenolol in the treatment of hypertension in diabetic patients.
    Elving LD, de Nobel E, van Lier HJ, Thien T.
    J Clin Pharmacol; 1989 Apr; 29(4):316-20. PubMed ID: 2656775
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of ketanserin on transmembrane sodium transport in erythrocytes.
    Sechi LA, Tedde R, Cassisa L, Marigliano A, Uneddu F, Melis A, Pala A.
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):269-75. PubMed ID: 1689423
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.